Clinical Trial Update: A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis [Phase 4]

View source ↗

Summary

This update describes a Phase 4 safety and pharmacokinetics study of IDP-122 Lotion in pediatric participants with plaque psoriasis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• IDP-122 Lotion

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Psoriasis | Phase 4 | Status: RECRUITING